We are live on ! Find out more
ASLN

ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN

Delisted

ASLN was delisted on the 18th of July, 2024.

Back to rankings

1 hedge funds and large institutions have $17 invested in ASLAN Pharmaceuticals Limited American Depositary Shares in 2026 Q1 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 1 → 1 (0)

0% more capital invested

Capital invested by funds: $17 → $17 ($0)

Holders
1
Holders Change
–
Holders Change %
0%
% of All Funds
0.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
RhumbLine Advisers
1
RhumbLine Advisers
Massachusetts
$17 – – –

ASLN Hedge Fund Activity: Q1 2026 in Review

1 of the 8,127 institutional investors tracked by Wall St. Rank reported a position in ASLAN Pharmaceuticals Limited American Depositary Shares (ASLN) for Q1 2026, worth a combined $17 — unchanged from a quarter earlier.

Fund positioning in ASLN was balanced in Q1 2026: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 1 institutional investor held ASLAN Pharmaceuticals Limited American Depositary Shares (ASLN) as of Q1 2026, unchanged from Q4 2025.
  • Funds reported $17 of ASLAN Pharmaceuticals Limited American Depositary Shares stock for Q1 2026, unchanged quarter-over-quarter.
  • 0 funds opened new ASLAN Pharmaceuticals Limited American Depositary Shares positions in Q1 2026 and 0 closed out.

Based on aggregated 13F filings for Q1 2026.